Yüklüyor......

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α

PURPOSE: Hypoxic tumor cells overexpressing hypoxia-inducible factor 1alpha (HIF-1α) are generally resistant to chemo/radiotherapy. We have reported that Se-methylselenocysteine (MSC) therapeutically enhances the efficacy and selectivity of irinotecan against human tumor xenografts. The aim of this...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chintala, Sreenivasulu, Tóth, Károly, Cao, Shousong, Durrani, Farukh A., Vaughan, Mary M., Jensen, Randy L., Rustum, Youcef M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916970/
https://ncbi.nlm.nih.gov/pubmed/20066420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1238-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!